
PRESS RELEASE: EORTC 1945 OligoRARE trial in oligometastatic rare cancers receives support by Anticancer Fund & Rising Tide Foundation
2 Feb 2021

PRESS RELEASE: First Patients Tested with InVisionFirst®-Lung in EORTC Sponsored Phase II NSCLC Study
20 Jan 2021

PRESS RELEASE: KEYTRUDA® (pembrolizumab) Reduced the Risk of Distant Metastasis or Death by 40% Compared Versus Placebo as Adjuvant Treatment in Resected, High-Risk Stage III Melanoma
19 Sep 2020

PRESS RELEASE: Advocacy Organizations and Professional Societies from Across the Globe Unite on Brain Tumour Patients’ Charter of Rights
16 Jul 2020

PRESS RELEASE: EORTC and CDDF announce new collaboration
18 Jun 2020

PRESS RELEASE : Significant PIONEER milestone – First two datasets uploaded into the PIONEER Big Data platform
19 Feb 2020

PRESS RELEASE: Researchers develop first international standards for quality of life measurement in cancer
31 Jan 2020

PRESS RELEASE: Study shows importance of Quality of Life scores as prognostic factors in cancer patients
3 Dec 2019